Systematic error in gas chromatography-mass spectrometry-based quantification of hydrolyzed urinary steroids

Ju Yeon Moon, Young Wan Ha, Myeong Hee Moon, Bong Chul Chung, Man Ho Choi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Gas chromatography-mass spectrometry-based metabolite profiling can lead to an understanding of various disease mechanisms as well as to identifying new diagnostic biomarkers by comparing the metabolites related in quantification. However, the unexpected transformation of urinary steroids during enzymatic hydrolysis with Helix pomatia could result in an underestimation or overestimation of their concentrations. A comparison of β-glucurondase extracted from Escherichia coli revealed 18 conversions of 84 steroids tested as an unexpected transformation under hydrolysis with β-glucuronidase/ arylsulfatase extracted from Helix pomatia. In addition to the conversion of 3β-hydroxy-5-ene steroids into 3-oxo-4-ene steroids, which has been reported, the transformation of 3β-hydroxy-5α-reduced and 3β-hydroxy-5β-reduced steroids to 3-oxo-5α-reduced and 3-oxo-5β-reduced steroids, respectively, was newly observed. The formation of by-products was in proportion to the concentration of substrates becoming saturated against the enzyme. The substances belonging to these three steroid groups were undetectable at low concentrations, whereas the corresponding by-products were overestimated. These results indicate that the systematic error in the quantification of urinary steroids hydrolyzed with Helix pomatia can lead to a misreading of the clinical implications. All these hydrolysis procedures are suitable for study purposes, and the information can help prevent false evaluations of urinary steroids in clinical studies.

Original languageEnglish
Pages (from-to)388-397
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number2
DOIs
Publication statusPublished - 2010 Feb 1

Fingerprint

Gas Chromatography-Mass Spectrometry
Steroids
Hydrolysis
Arylsulfatases
Glucuronidase
Biomarkers
Escherichia coli
Enzymes

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology

Cite this

@article{1304f96b9fa343a69b432714cc359914,
title = "Systematic error in gas chromatography-mass spectrometry-based quantification of hydrolyzed urinary steroids",
abstract = "Gas chromatography-mass spectrometry-based metabolite profiling can lead to an understanding of various disease mechanisms as well as to identifying new diagnostic biomarkers by comparing the metabolites related in quantification. However, the unexpected transformation of urinary steroids during enzymatic hydrolysis with Helix pomatia could result in an underestimation or overestimation of their concentrations. A comparison of β-glucurondase extracted from Escherichia coli revealed 18 conversions of 84 steroids tested as an unexpected transformation under hydrolysis with β-glucuronidase/ arylsulfatase extracted from Helix pomatia. In addition to the conversion of 3β-hydroxy-5-ene steroids into 3-oxo-4-ene steroids, which has been reported, the transformation of 3β-hydroxy-5α-reduced and 3β-hydroxy-5β-reduced steroids to 3-oxo-5α-reduced and 3-oxo-5β-reduced steroids, respectively, was newly observed. The formation of by-products was in proportion to the concentration of substrates becoming saturated against the enzyme. The substances belonging to these three steroid groups were undetectable at low concentrations, whereas the corresponding by-products were overestimated. These results indicate that the systematic error in the quantification of urinary steroids hydrolyzed with Helix pomatia can lead to a misreading of the clinical implications. All these hydrolysis procedures are suitable for study purposes, and the information can help prevent false evaluations of urinary steroids in clinical studies.",
author = "Moon, {Ju Yeon} and Ha, {Young Wan} and Moon, {Myeong Hee} and Chung, {Bong Chul} and Choi, {Man Ho}",
year = "2010",
month = "2",
day = "1",
doi = "10.1158/1055-9965.EPI-09-0581",
language = "English",
volume = "19",
pages = "388--397",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

Systematic error in gas chromatography-mass spectrometry-based quantification of hydrolyzed urinary steroids. / Moon, Ju Yeon; Ha, Young Wan; Moon, Myeong Hee; Chung, Bong Chul; Choi, Man Ho.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 2, 01.02.2010, p. 388-397.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systematic error in gas chromatography-mass spectrometry-based quantification of hydrolyzed urinary steroids

AU - Moon, Ju Yeon

AU - Ha, Young Wan

AU - Moon, Myeong Hee

AU - Chung, Bong Chul

AU - Choi, Man Ho

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Gas chromatography-mass spectrometry-based metabolite profiling can lead to an understanding of various disease mechanisms as well as to identifying new diagnostic biomarkers by comparing the metabolites related in quantification. However, the unexpected transformation of urinary steroids during enzymatic hydrolysis with Helix pomatia could result in an underestimation or overestimation of their concentrations. A comparison of β-glucurondase extracted from Escherichia coli revealed 18 conversions of 84 steroids tested as an unexpected transformation under hydrolysis with β-glucuronidase/ arylsulfatase extracted from Helix pomatia. In addition to the conversion of 3β-hydroxy-5-ene steroids into 3-oxo-4-ene steroids, which has been reported, the transformation of 3β-hydroxy-5α-reduced and 3β-hydroxy-5β-reduced steroids to 3-oxo-5α-reduced and 3-oxo-5β-reduced steroids, respectively, was newly observed. The formation of by-products was in proportion to the concentration of substrates becoming saturated against the enzyme. The substances belonging to these three steroid groups were undetectable at low concentrations, whereas the corresponding by-products were overestimated. These results indicate that the systematic error in the quantification of urinary steroids hydrolyzed with Helix pomatia can lead to a misreading of the clinical implications. All these hydrolysis procedures are suitable for study purposes, and the information can help prevent false evaluations of urinary steroids in clinical studies.

AB - Gas chromatography-mass spectrometry-based metabolite profiling can lead to an understanding of various disease mechanisms as well as to identifying new diagnostic biomarkers by comparing the metabolites related in quantification. However, the unexpected transformation of urinary steroids during enzymatic hydrolysis with Helix pomatia could result in an underestimation or overestimation of their concentrations. A comparison of β-glucurondase extracted from Escherichia coli revealed 18 conversions of 84 steroids tested as an unexpected transformation under hydrolysis with β-glucuronidase/ arylsulfatase extracted from Helix pomatia. In addition to the conversion of 3β-hydroxy-5-ene steroids into 3-oxo-4-ene steroids, which has been reported, the transformation of 3β-hydroxy-5α-reduced and 3β-hydroxy-5β-reduced steroids to 3-oxo-5α-reduced and 3-oxo-5β-reduced steroids, respectively, was newly observed. The formation of by-products was in proportion to the concentration of substrates becoming saturated against the enzyme. The substances belonging to these three steroid groups were undetectable at low concentrations, whereas the corresponding by-products were overestimated. These results indicate that the systematic error in the quantification of urinary steroids hydrolyzed with Helix pomatia can lead to a misreading of the clinical implications. All these hydrolysis procedures are suitable for study purposes, and the information can help prevent false evaluations of urinary steroids in clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=76149128689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149128689&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0581

DO - 10.1158/1055-9965.EPI-09-0581

M3 - Article

C2 - 20086107

AN - SCOPUS:76149128689

VL - 19

SP - 388

EP - 397

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 2

ER -